VIP and rheumatoid arthritis: In addition, studies have shown that TGF-β, vasoactive intestinal peptide (VIP) and immunoglobulin D (Immunoglobulin D, IgD)-Fc-Ig play an important role in targeting Tregs to restore immune tolerance in RA.